Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    17030655 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed OmegAD (Omega-3 and Alzheimer's Disease)
Condition: Alzheimer's Disease
Intervention: Drug: EPAX 1050TG
2 Enrolling by invitation Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's
Conditions: Nutrition;   Fatty Acids, Omega-3;   Cognition;   Resilience, Psychological;   Psychology, Military
Interventions: Dietary Supplement: Phospholipid-bound omega-3 supplement;   Dietary Supplement: Placebo supplement
3 Completed Short Term Efficacy and Safety of Perispinal Administration of Etanercept in Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: Etanercept;   Dietary Supplement: Curcum.Luteol.Theaflav.Lip.Acid,FishOil,Quercet.,Resveratr.

Study has passed its completion date and status has not been verified in more than two years.